BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 78763)

  • 1. Antigens on human tumor cells assayed by complement fixation with allogeneic sera.
    Gupta RK; Irie RF; Morton DL
    Cancer Res; 1978 Aug; 38(8):2573-80. PubMed ID: 78763
    [No Abstract]   [Full Text] [Related]  

  • 2. Sarcoma-specific antigens: detection by complement fixation with serum from sarcoma patients.
    Eilber FR; Morton DL
    J Natl Cancer Inst; 1970 Mar; 44(3):651-6. PubMed ID: 11515434
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific antigens of a chemically induced tumor; detection by complement fixation.
    Albright NL; Myers GH
    J Natl Cancer Inst; 1972 Jul; 49(1):295-7. PubMed ID: 5037437
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
    [No Abstract]   [Full Text] [Related]  

  • 6. Osteosarcoma patients: isolation of serum antibodies by affinity chromatography.
    Tsang KY; Fudenberg HH; Gnagy MJ
    J Natl Cancer Inst; 1981 Dec; 67(6):1183-9. PubMed ID: 6796743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of common sarcoma-associated antigen(s) in an established human neurogenic sarcoma cell line.
    Drewinko B; Montgomery CT; Trujillo JM
    Cancer Res; 1973 Mar; 33(3):601-5. PubMed ID: 4347719
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on purification of antibodies against tumor-specific antigens.
    Park MM
    Pahlavi Med J; 1978 Jan; 9(1):1-26. PubMed ID: 652378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed cutaneous hypersensitivity to cell-free tumor antigens.
    Holmes EC; Reisfeld RA; Morton DL
    Cancer Res; 1973 Feb; 33(2):199-202. PubMed ID: 4510928
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration of two distinct antigens in spent tissue culture medium of a human malignant melanoma cell line.
    Gupta RK; Irie RF; Chee DO; Kern DH; Morton DL
    J Natl Cancer Inst; 1979 Aug; 63(2):347-56. PubMed ID: 88538
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of short-term culture on the sensitivity of MDAY murine tumor cells tolysis mediated by normal rabbit serum.
    Caspi R; Witz IP
    Eur J Immunol; 1976 Mar; 6(3):174-9. PubMed ID: 1033065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reacting tumor-specific transplantation antigens in methylcholanthrene-induced guinea pig sarcomas.
    Holmes EC; Morton DL; Schidlovsky G; Trahan E
    J Natl Cancer Inst; 1971 Apr; 46(4):693-700. PubMed ID: 4102340
    [No Abstract]   [Full Text] [Related]  

  • 13. [New data on experimental tumor immunology].
    Schneeweiss U; Gummel H
    Z Exp Chir; 1972; 5(2):66-80. PubMed ID: 4680973
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of oncofetal antigens by murine and human normal cells in tissue culture.
    Rosenberg SA; Parker GA; Thorpe WP
    Isr J Med Sci; 1978 Jan; 14(1):98-104. PubMed ID: 273017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative immunofluorescence studies of the tumor antigen-bearing cell in giant cell tumor of bone and osteogenic sarcoma.
    Byers VS; Levin AS; Johnston JO; Hackett AJ
    Cancer Res; 1975 Sep; 35(9):2520-31. PubMed ID: 1097109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characterizations of tumor-associated fetal antigens.
    Evans DL; Frank MK; McKinnon KP; Cerrone M
    Cancer Res; 1979 Jun; 39(6 Pt 1):2016-25. PubMed ID: 87259
    [No Abstract]   [Full Text] [Related]  

  • 17. A model for human osteosarcoma in hamsters.
    Singh I; Tsang KY; Blakemore WS
    Clin Orthop Relat Res; 1979 Oct; (144):305-10. PubMed ID: 294956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
    Morton DL; Eilber FR; Malmgren RA
    Prog Exp Tumor Res; 1971; 14():25-42. PubMed ID: 5002728
    [No Abstract]   [Full Text] [Related]  

  • 20. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
    Imai K; Ferrone S
    Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.